cho_logo_symbol_border
  • (800) 266-7207 | 30 Wall St. 8th Floor New York, NY 10005
  • Mon - Fri: 8:00 am - 5:00 pm

News

CDC opening applications for Monkeypox Vaccine Equity Pilot Program
"Today, local, state, and territorial health departments, as well as tribal governments and local non-governmental organizations, can partner together and
Monkeypox Cases Still on the Rise
As of September 14th, 61,282 confirmed or probable cases have been identified globally. 23,499 of those are in the United
US Orders 100 Million COVID Tests, White House Says More Needed
"The United States will boost its stockpile of at-home COVID-19 tests, ordering more than 100 million tests from domestic manufacturers,
Another New COVID Variant is Spreading – Enter BA.4.6
"BA.4.6, a subvariant of the omicron COVID variant which has been quickly gaining traction in the US, is now confirmed to
New Omicron offshoot BA.4.6 evades protection of Evusheld’s antibodies, study finds
(CNN) - "The antibodies in Evusheld, the only therapy available to protect people with reduced immune function against Covid-19, may lose
“Game-changer” Paxlovid turns into pandemic enigma
"Paxlovid, once hailed as a "game-changer" for its ability to treat COVID-19 infections at home, is becoming one of the pandemic's biggest
A third COVID Autumn is Upon Us
Each new season brings new hope of a possible end to the pandemic, but forecasts say we should not be
Texas reports what may be the first U.S. death from monkeypox
Monkeypox is a serious disease, especially coupled with immune systems that have taken down by the Coronavirus. Since the beginning
A dog in France has monkeypox, worrying scientists that we won’t be able to eradicate the virus if it spreads...
In recent times, the world has been facing our latest battles against viruses. Complicating factors like the virus's ability to
COVID Test for Pets
A COVID Test for Pets?
As COVID Becomes Part of Every Day Life, One Company Creates a New Test for Mans Best Friend   NEW

Disclaimer

Clear Health Pass Safe Harbor Exemption
The information on this website does not constitute an offer to sell or solicitation of an offer to buy securities by anyone in any jurisdiction which would be considered unlawful. Clear Health Pass Holdings, LLC’s offering is under Rule 506(c) of Regulation D and is considered a “safe harbor” for the private offering exemption of Section 4(a)(2) of the Securities Act. To be eligible to receive qualified investment status, you must be an accredited investor as defined by Section 2(15)(ii) of the Securities Act of 1933.

© 2023 Clear Health Pass Holdings™, LLC., All trademark references are trademarks of either the Clear Health Pass Holdings, LLC or their respective owners.

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Click here to Download Our Investment Package

Skip to content